Please provide your email address to receive an email when new articles are posted on . “Vascular access is the Achilles’ heel of dialysis therapy.” That is an often-quoted statement in dialysis ...

Please provide your email address to receive an email when new articles are posted on . For older patients who initiated hemodialysis without permanent access, those with arteriovenous fistula ...

More than a third of patients required interventions to foster AVF maturation. Intervention is commonly required to foster maturation of arteriovenous fistulas (AVFs), maintain patency, and treat ...

An investigational product called Acellular Tissue Engineered Vessel demonstrated superior hemodialysis vascular access outcomes compared with AVFs in a phase 3 trial. A bioengineered human tissue ...

The Ellipsys Vascular Access System reduces the time before patients with kidney failure can start lifesaving dialysis treatments, while requiring fewer secondary procedures, according to a new study ...

North Chesterfield, Va. - The Ellipsys Vascular Access System reduces the time before patients with kidney failure can start lifesaving dialysis treatments, while requiring fewer secondary procedures, ...

BIRMINGHAM, Ala. – More than 600,000 people in the United States have end-stage kidney disease, and about 450,000 are kept alive through chronic hemodialysis to remove waste products from their blood.

Timmy Lee, MD, MSPH, is Associate Professor of Medicine in the Division of Nephrology and Staff Nephrologist at the Birmingham Veterans Affairs Medical Center. He is the Associate Director of ...

SALT LAKE CITY--(BUSINESS WIRE)--Alucent Biomedical Inc., a company dedicated to developing and commercializing its breakthrough AlucentNVS technology for the treatment of vascular disease, announced ...

This requires durable access to a blood vessel site where the dialysis machine can remove and return blood. Such access is created when a surgeon attaches a vein to an artery in the patient. The ...